Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Thibault

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Toxicological Sciences|October 8, 2019
Central nervous system tumors in 2-year rat carcinogenicity studies: perspectives on human risk assessmentAida Sacaan, Stephane Thibault, K Nasir Khan
Toxicologic Pathology|June 16, 2025
Deep Learning Methodology for Quantification of Normal Pancreas StructuresZhiyong Xie, Stephane Thibault, Norimitsu Shirai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic ChemotherapiesWenyue Hu, Tae Sung, Bart A Jessen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
Nonclinical Profile of PF-06952229 (MDV6058), a Novel TGFβRI/Activin Like Kinase 5 Inhibitor Supports Clinical Evaluation in CancerMausumee Guha, Stephane Thibault, Son Pham, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 22, 2021
Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational ToxicityWenyue Hu, Daniel Lettiere, Susanna Tse, et al.
Toxicologic Pathology|December 27, 2016
Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in RatsJianying Wang, Wenhu Huang, Stephane Thibault, et al.
Molecular Cancer Therapeutics|November 8, 2018
Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary PharmacologyStephane Thibault, Wenyue Hu, Brad Hirakawa, et al.
International Journal of Hematology|October 22, 2013
Cardiovascular differentiation of imatinib and bosutinib in the ratJonathan R Heyen, Wenyue Hu, Joseph Jamieson, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2013
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncologyStanley A Roberts, Paul A Andrews, Diann Blanset, et al.
Molecular Cancer Research : MCR|August 2, 2017
CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged RatsAida I Sacaan, Stephane Thibault, Miyoun Hong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Toxicological Sciences|October 8, 2019
Central nervous system tumors in 2-year rat carcinogenicity studies: perspectives on human risk assessmentAida Sacaan, Stephane Thibault, K Nasir Khan
Toxicologic Pathology|June 16, 2025
Deep Learning Methodology for Quantification of Normal Pancreas StructuresZhiyong Xie, Stephane Thibault, Norimitsu Shirai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic ChemotherapiesWenyue Hu, Tae Sung, Bart A Jessen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
Nonclinical Profile of PF-06952229 (MDV6058), a Novel TGFβRI/Activin Like Kinase 5 Inhibitor Supports Clinical Evaluation in CancerMausumee Guha, Stephane Thibault, Son Pham, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 22, 2021
Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational ToxicityWenyue Hu, Daniel Lettiere, Susanna Tse, et al.
Toxicologic Pathology|December 27, 2016
Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in RatsJianying Wang, Wenhu Huang, Stephane Thibault, et al.
Molecular Cancer Therapeutics|November 8, 2018
Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary PharmacologyStephane Thibault, Wenyue Hu, Brad Hirakawa, et al.
International Journal of Hematology|October 22, 2013
Cardiovascular differentiation of imatinib and bosutinib in the ratJonathan R Heyen, Wenyue Hu, Joseph Jamieson, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2013
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncologyStanley A Roberts, Paul A Andrews, Diann Blanset, et al.
Molecular Cancer Research : MCR|August 2, 2017
CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged RatsAida I Sacaan, Stephane Thibault, Miyoun Hong, et al.
Pageof 2